|1.||Motrescu, Elena: 3 articles (01/2004 - 01/2003)|
|2.||Brischwein, Martin: 3 articles (01/2004 - 01/2003)|
|3.||Otto, Angela M: 3 articles (01/2004 - 01/2003)|
|4.||Wolf, Bernhard: 3 articles (01/2004 - 01/2003)|
|5.||Wolf, B: 2 articles (12/2013 - 10/2005)|
|6.||Brischwein, M: 2 articles (12/2013 - 10/2005)|
|7.||Koren, Gideon: 2 articles (07/2009 - 06/2006)|
|8.||Aleksa, Katarina: 2 articles (07/2009 - 06/2006)|
|9.||Grothe, Helmut: 2 articles (01/2004 - 01/2003)|
|10.||Ranninger, Christina: 1 article (07/2015)|
07/31/2015 - "Here we describe a long term repeat dose nephrotoxicity study conducted on the human renal proximal tubular epithelial cell line, RPTEC/TERT1, treated with 10 and 35 μmol·liter(-1) of chloroacetaldehyde, a metabolite of the anti-cancer drug ifosfamide. "
04/01/2010 - "Chloroacetaldehyde (CAA), a product of hepatic metabolism of the widely used anticancer drug ifosfamide (IFO), has been reported to decrease cancer cell proliferation. "
07/01/2009 - "Ifosfamide (IF), a potent chemotherapeutic agent for solid tumors, is known to cause high rates of nephrotoxicity in children with cancer, which is most likely due to the renal production of the metabolite chloroacetaldehyde. "
06/01/2006 - "Ifosfamide (IF), a potent chemotherapeutic agent for solid tumors, is known to cause high rates of nephrotoxicity, which is most likely due to the renal production of the metabolite chloroacetaldehyde. "
02/01/2006 - "In summary, our results show that chloroacetaldehyde influences the oxidative phosphorylation in mitochondria, however, this is observed only in high concentrations and is not of clinical relevance because the tumor cells regenerate ATP by anaerobic glycolysis. "
|2.||Breast Neoplasms (Breast Cancer)
12/15/2013 - "To demonstrate the performance of the platform in physiologic assays, we continuously recorded the kinetics of metabolic and morphologic parameters of MCF-7 breast cancer cells under the influence of the cytotoxin chloroacetaldehyde. "
01/01/2003 - "Primary breast cancer cells also responded to chloroacetaldehyde with a marked reduction in deltapO2, followed by a reduced rate of acidification. "
01/01/2003 - "In this study, colon and breast cancer cells as well as doxorubicin-sensitive and doxorubicin-resistant sarcoma cell lines were exposed to cytochalasin B, chloroacetaldehyde, or doxorubicin. "
04/01/2010 - "Ifosfamide metabolite chloroacetaldehyde inhibits cell proliferation and glucose metabolism without decreasing cellular ATP content in human breast cancer cells MCF-7."
01/01/2004 - "Experiments with LS174T colon carcinoma cells in culture show the metabolic and electrical changes upon incubation with Zytochalasin B and chloroacetaldehyde. "
10/01/2005 - "To study the interplay of drugs and energy metabolism of tumor cells, metabolic changes induced by chloroacetaldehyde and cytochalasin B were analyzed in colon carcinoma cells LS174T. "
02/01/2006 - "MX-1 breast carcinoma cells were measured for ATP-content after exposure to chloroacetaldehyde. "
06/01/1989 - "Based on clinical data, indicating that chloroacetaldehyde (CAA) is an important metabolite of oxazaphosphorine cytostatics, an experimental study was carried out in order to elucidate the role of CAA in the development of hemorrhagic cystitis. "
01/01/2003 - "Acrolein may induce hemorrhagic cystitis, whereas chloroacetaldehyde may be responsible both for nephro- and neurotoxicity. "
|5.||Xeroderma Pigmentosum (Kaposi's Disease)
06/03/2004 - "The present study examines the role of the BER enzyme 3-alkyladenine DNA glycosylase (AAG) and the NER protein xeroderma pigmentosum group A (XPA) in protecting cerebellar neurons and astrocytes from chloroacetaldehyde (CAA) or the alkylating agent 3-methyllexitropsin (Me-Lex), which produce ethenobases or 3-methyladenine (3-MeA), respectively. "
|4.||DNA Glycosylases (DNA Glycosylase)
|8.||DNA (Deoxyribonucleic Acid)
|9.||Adenosine Triphosphate (ATP)
|1.||Drug Therapy (Chemotherapy)